TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Biotech Fluidics AB
Closing information (x1000 EUR)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
9,599
|
9,094
|
6,881 |
Financial expenses |
0
![]() |
0
![]() |
0 |
Earnings before taxes |
1,098
|
1,315
|
1,002 |
EBITDA |
995
|
1,224
|
672 |
Total assets |
4,293
|
4,125
|
2,923 |
Current assets |
3,590
|
3,696
|
2,453 |
Current liabilities |
1,004
|
1,413
|
878 |
Equity capital |
3,097
|
2,571
|
1,913 |
- share capital |
9
![]() |
9
|
10 |
Employees (average) |
13
![]() |
13
|
12 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
72.1%
|
62.3%
|
65.4% |
Turnover per employee |
738
|
700
|
573 |
Profit as a percentage of turnover |
11.4%
|
14.5%
|
14.6% |
Return on assets (ROA) |
25.6%
|
31.9%
|
34.3% |
Current ratio |
357.6%
|
261.6%
|
279.4% |
Return on equity (ROE) |
35.5%
|
51.1%
|
52.4% |
Change turnover |
478
|
2,770
|
1,449 |
Change turnover % |
5%
|
44%
|
27% |
Chg. No. of employees |
0
|
1
|
0 |
Chg. No. of employees % |
0%
|
8%
|
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.